Cargando…
Low plasma levels of miR-101 are associated with tumor progression in gastric cancer
BACKGROUND: Several studies have identified the decreased expression of the tumor suppressor miR-101 in various cancers. In this study, we tested miR-101 as a potential therapeutic target and novel plasma biomarker for gastric cancer (GC). RESULTS: The miR-101 expression level was significantly lowe...
Autores principales: | Imamura, Taisuke, Komatsu, Shuhei, Ichikawa, Daisuke, Miyamae, Mahito, Okajima, Wataru, Ohashi, Takuma, Kiuchi, Jun, Nishibeppu, Keiji, Kosuga, Toshiyuki, Konishi, Hirotaka, Shiozaki, Atsushi, Okamoto, Kazuma, Fujiwara, Hitoshi, Otsuji, Eigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739754/ https://www.ncbi.nlm.nih.gov/pubmed/29290969 http://dx.doi.org/10.18632/oncotarget.20860 |
Ejemplares similares
-
Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction
por: Aratani, Kenichi, et al.
Publicado: (2017) -
Correction: Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction
por: Aratani, Kenichi, et al.
Publicado: (2019) -
Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
por: Ohashi, Takuma, et al.
Publicado: (2017) -
Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids
por: Okajima, Wataru, et al.
Publicado: (2017) -
Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer
por: Imamura, Taisuke, et al.
Publicado: (2017)